Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRZO
3301
PUT
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $412K | ﹤0.01% |
11,500
-200
| -2% | -$7.15K |
|
3302
CALL
Fortinet
FTNT
$117B
| $411K | ﹤0.01% |
65,000
-617,000
| -90% | -$4M |
|
3303
Galicia Financial Group
GGAL
$7.42B
| $411K | ﹤0.01% |
+13,471
| New | +$388K |
|
3304
PUT
Sempra
SRE
$55.9B
| $410K | ﹤0.01% |
7,200
-8,600
| -54% | -$456K |
|
3305
Tootsie Roll Industries
TR
$3.01B
| $410K | ﹤0.01% |
14,309
-135
| -0.9% | -$3.6K |
|
3306
Ternium
TX
$10.5B
| $410K | ﹤0.01% |
21,482
+16,246
| +310% | +$307K |
|
|
HZNP
3307
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $410K | ﹤0.01% |
+24,900
| New | +$403K |
|
|
CCEC
3308
Capital Clean Energy Carriers
CCEC
$1.37B
| $409K | ﹤0.01% |
19,604
-1,875
| -9% | -$39.3K |
|
|
FARM
3309
DELISTED
Farmer Brothers
FARM
| $408K | ﹤0.01% |
12,700
-1,900
| -13% | -$56.8K |
|
|
BPL
3310
PUT
DELISTED
Buckeye Partners, L.P.
BPL
| $408K | ﹤0.01% |
5,800
+4,000
| +222% | +$280K |
|
3311
iShares Select Dividend ETF
DVY
$23.6B
| $407K | ﹤0.01% |
4,769
+1,869
| +64% | +$154K |
|
3312
CALL
InterDigital
IDCC
$8.88B
| $406K | ﹤0.01% |
7,300
-26,400
| -78% | -$1.49M |
|
|
XYZ
3313
CALL
Block Inc
XYZ
$47.4B
| $406K | ﹤0.01% |
44,900
+15,900
| +55% | +$180K |
|
|
TESO
3314
DELISTED
Tesco Corp
TESO
| $406K | ﹤0.01% |
60,663
+26,201
| +76% | +$203K |
|
|
HBI
3315
PUT
DELISTED
Hanesbrands
HBI
| $405K | ﹤0.01% |
16,100
+7,800
| +94% | +$213K |
|
3316
HEICO Corp Class A
HEI.A
$36.8B
| $403K | ﹤0.01% |
18,367
+8,245
| +81% | +$174K |
|
3317
PUT
iShares Russell 1000 Value ETF
IWD
$83.6B
| $403K | ﹤0.01% |
3,900
-3,000
| -43% | -$303K |
|
3318
Protalix BioTherapeutics
PLX
$197M
| $403K | ﹤0.01% |
62,959
-6,479
| -9% | -$51.8K |
|
|
XONE
3319
DELISTED
The ExOne Company
XONE
| $403K | ﹤0.01% |
38,104
+36,672
| +2,561% | +$414K |
|
3320
CALL
iShares Russell 1000 Growth ETF
IWF
$128B
| $401K | ﹤0.01% |
16,000
+10,000
| +167% | +$250K |
|
3321
Steven Madden
SHOO
$3.54B
| $401K | ﹤0.01% |
17,570
+2,888
| +20% | +$66.4K |
|
|
ISIL
3322
CALL
DELISTED
Intersil Corp
ISIL
| $401K | ﹤0.01% |
29,600
-400
| -1% | -$5.2K |
|
|
ARIA
3323
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $400K | ﹤0.01% |
54,100
+40,000
| +284% | +$300K |
|
|
HCR
3324
CALL
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $399K | ﹤0.01% |
30,500
+29,400
| +2,673% | +$239K |
|
3325
Healthcare Realty
HR
$6.91B
| $398K | ﹤0.01% |
12,306
-105
| -0.8% | -$3.16K |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.